Staging and Multidisciplinary Management of Patients with Early-Stage Non–Small Cell Lung Cancer

Publication Date: June 10, 2023
Last Updated: August 15, 2023

Optimal diagnosis and staging

Appropriate staging of patients with newly diagnosed lung cancer should include CT and PET imaging. In addition, brain imaging and invasive mediastinal staging should be performed where clinically indicated. (I, B-R)
573

Neoadjuvant therapy

For medically operable patients with oncologically resectable stage III NSCLC with N2 disease for whom surgery is planned, preoperative systemic therapy without radiotherapy is recommended. For those patients with superior sulcus tumors and no evidence of N2 disease, neoadjuvant concurrent chemoradiotherapy is preferred. (IIa, B-NR)
573

Overview

Title

Staging and Multidisciplinary Management of Patients with Early-Stage Non–Small Cell Lung Cancer

Authoring Organization